COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Leukos Biotech, a Barcelona-based company developing drugs that target leukemic stem cells, is advancing an AML candidate into clinical trials for patients aged 60+ ineligible for transplant or chemotherapy.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor